|
Name of the product: METFORMINA AP 500 DOSA (*)
Active ingredient: Metformin 500 mg (as metformin hydrochloride)
Dosage form: extended-release film-coated tablets
Name of the product: METFORMINA METFORMINA AP 850 DOSA (*)
Active ingredient: Metformin 850 mg (as metformin hydrochloride)
Dosage form: extended-release film-coated tablets
Name of the product: METFORMINA 500 DOSA (*)
Active ingredient: Metformin 500 mg (as metformin hydrochloride)
Dosage form: film-coated tablets
Name of the product: METFORMINA 850 DOSA (*)
Active ingredient: Metformin 850 mg (as metformin hydrochloride)
Dosage form: film-coated tablets
Name of the product: METFORMINA 1000 DOSA (*)
Active ingredient: Metformin 1000 mg (as metformin hydrochloride)
Dosage form: film-coated tablets
Dispensing requirements: Rx only
Argentine Industry
Composition:
METFORMINA 500 AP DOSA:
Each extended-release film-coated tablet contains metformin 500 mg (as metformin hydrochloride), anhydrous lactose, Ac Di Sol, povidone, magnesium stearate, Opadry, titanium dioxide, micronised talc, and yellow ferric oxide.
METFORMINA 850 AP DOSA:
Each extended-release film-coated tablet contains metformin 850 mg (as metformin hydrochloride), anhydrous lactose, Ac Di Sol, povidone, magnesium stearate, Opadry, titanium dioxide, micronised talc, and blue aluminium lake.
METFORMINA 500 DOSA:
Each film-coated tablet contains metformin 500 mg (as metformin hydrochloride), anhydrous lactose, Ac Di Sol, povidone, magnesium stearate, Opadry, titanium dioxide, and micronised talc.
METFORMINA 850 DOSA:
Each film-coated tablet contains metformin 850 mg (as metformin hydrochloride), anhydrous lactose, Ac Di Sol, povidone, magnesium stearate, Opadry, titanium dioxide, micronised talc, and yellow lake.
METFORMINA 1000 DOSA:
Each film-coated tablet contains metformin 1000 mg (as metformin hydrochloride), anhydrous lactose, Ac Di Sol, povidone, magnesium stearate, Opadry, titanium dioxide, micronised talc, and quinoline yellow.
Indications:
METFORMINA AP DOSA and MERTFORMINA DOSA are indicated for the treatment of the non-insulin-dependent diabetes mellitus in patients whose hyperglucemia cannot be controlled only with diet, exercises, or weight reduction, or when the insulin therapy is not required or non practicable. They are used in single therapy or in combination with sulphonylurea in patients with diabetes type II; also, as an adjunct in insulin therapy in patients with diabetes type I (DMID): unstable diabetes, insulin resistant diabetes.
Therapeutic action:
Hypoglucemiant.
Storage:
Keep at temperature between 15º and 30º C in the marketed packing.
Marketed presentations:
METFORMINA AP 500 DOSA:
Packs containing 30, 60 and 100 film-coated tablets.
Packs containing 500 film-coated tablets, for use in hospital.
METFORMINA AP 850 DOSA:
Packs containing 30, 60 and 100 film-coated tablets.
Packs containing 500 film-coated tablets, for use in hospital.
METFORMINA 500 DOSA:
Packs containing 30, 60 and 100 film-coated tablets.
Packs containing 500 film-coated tablets, for use in hospital.
METFORMINA 850 DOSA:
Packs containing 30, 60 and 100 film-coated tablets.
Packs containing 500 film-coated tablets, for use in hospital.
METFORMINA 1000 DOSA:
Packs containing 30, 60 and 100 film-coated tablets.
Packs containing 500 film-coated tablets, for use in hospital.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 52587
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) Buenos Aires, Argentine
Pharmaceutical Director: María C. Terzo, Pharmacist
|
